| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and … M Rybak, B Lomaestro, JC Rotschafer, R Moellering Jr, W Craig, ... American Journal of Health-System Pharmacy 66 (1), 82-98, 2009 | 2170 | 2009 |
| Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the … MJ Rybak, J Le, TP Lodise, DP Levine, JS Bradley, C Liu, BA Mueller, ... American Journal of Health-System Pharmacy 77 (11), 835-864, 2020 | 1055 | 2020 |
| Application of fluoroquinolone pharmacodynamics DH Wright, GH Brown, ML Peterson, JC Rotschafer Journal of Antimicrobial Chemotherapy 46 (5), 669-683, 2000 | 441 | 2000 |
| Therapeutic monitoring of vancomycin in adults: summary of consensus recommendations from the American Society of Health‐System Pharmacists, the Infectious Diseases Society of … MJ Rybak, BM Lomaestro, JC Rotschafer, RC Moellering Jr, WA Craig, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (11 …, 2009 | 330 | 2009 |
| Vancomycin pharmacokinetics in patients with various degrees of renal function KA Rodvold, RA Blum, JH Fischer, HZ Zokufa, JC Rotschafer, ... Antimicrobial agents and chemotherapy 32 (6), 848-852, 1988 | 303 | 1988 |
| The importance of bactericidal drugs: future directions in infectious disease RW Finberg, RC Moellering, FP Tally, WA Craig, GA Pankey, EP Dellinger, ... Clinical infectious diseases 39 (9), 1314-1320, 2004 | 300 | 2004 |
| Clinical pharmacokinetics of ciprofloxacin K Vance-Bryan, DRP Guay, JC Rotschafer Clinical pharmacokinetics 19, 434-461, 1990 | 262 | 1990 |
| Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations JC Rotschafer, K Crossley, DE Zaske, K Mead, RJ Sawchuk, LD Solem Antimicrobial Agents and Chemotherapy 22 (3), 391-394, 1982 | 230 | 1982 |
| Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas … KJ Madaras-Kelly, BE Ostergaard, LB Hovde, JC Rotschafer Antimicrobial agents and chemotherapy 40 (3), 627-632, 1996 | 206 | 1996 |
| Synergistic Activity of Colistin and Ceftazidime against Multiantibiotic-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model BW Gunderson, KH Ibrahim, LB Hovde, TL Fromm, MD Reed, ... Antimicrobial agents and chemotherapy 47 (3), 905-909, 2003 | 199 | 2003 |
| Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations DE Zaske, RJ Cipolle, JC Rotschafer, LD Solem, NR Mosier, RG Strate Antimicrobial Agents and Chemotherapy 21 (3), 407-411, 1982 | 194 | 1982 |
| Polymyxins:: Pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications ED Hermsen, CJ Sullivan, JC Rotschafer Infectious Disease Clinics 17 (3), 545-562, 2003 | 146 | 2003 |
| The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic … AJ Larsson, KJ Walker, JK Raddatz, JC Rotschafer Journal of Antimicrobial Chemotherapy 38 (4), 589-597, 1996 | 140 | 1996 |
| What do we really know about antibiotic pharmacodynamics? BW Gunderson, GH Ross, KH Ibrahim, JC Rotschafer Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (11P2 …, 2001 | 132 | 2001 |
| Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique K Vance-Bryan, DR Guay, SS Gilliland, KA Rodvold, JC Rotschafer Antimicrobial agents and chemotherapy 37 (3), 436-440, 1993 | 132 | 1993 |
| Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model MW Garrison, K Vance-Bryan, TA Larson, JP Toscano, JC Rotschafer Antimicrobial agents and chemotherapy 34 (10), 1925-1931, 1990 | 127 | 1990 |
| Clostridium difficile Colonization in Residents of Long‐Term Care Facilities: Prevalence and Risk Factors KJ Walker, SS Gilliland, K Vance‐Bryan, JA Moody, AJ Larsson, ... Journal of the American Geriatrics Society 41 (9), 940-946, 1993 | 120 | 1993 |
| Gentamicin dosing errors with four commonly used nomograms TS Lesar, JC Rotschafer, LM Strand, LD Solem, DE Zaske JAMA 248 (10), 1190-1193, 1982 | 108 | 1982 |
| Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography DH Wright, VK Herman, FN Konstantinides, JC Rotschafer Journal of Chromatography B: Biomedical Sciences and Applications 709 (1 …, 1998 | 102 | 1998 |
| Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline … MJ Rybak, J Le, T Lodise, D Levine, J Bradley, C Liu, B Mueller, M Pai, ... Journal of the Pediatric Infectious Diseases Society 9 (3), 281-284, 2020 | 98 | 2020 |
Ronald SawchukProfessor of Pharmaceutics, University of Minnesota在 umn.edu 的电子邮件经过验证
